Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Redza-Dutordoir M, Averill-Bates DA
Published by Eli Lilly in December 2025, the results showed: Average weight loss of 28.7% at the 12mg dose over 68 weeks comparable to TRIUMPH-1 at the same dose Significant reductions in WOMAC pain scores a validated measure of knee pain and function More than 1 in 8 patients on retatrutide were completely free of knee pain by the end of the trial compared with less than 1 in 25 on placebo Significant improvements in physical function, stair climbing, and walking distance This matters clinically because knee osteoarthritis and obesity are deeply intertwined each kilogram of body weight lost reduces knee joint load by approximately 4 kilograms during walking
Patients can verify Direct Meds' current LegitScript certification status directly through the LegitScript website before enrolling
Figure 4 3.4 Result of the inconsistency analysis The results of the global inconsistency test are shown in Supplementary File 3 ( Table 1 )
